about the same as the 25th ranked company on GEN’s Top 25 Biotech Companies of 2024. Just missing the list at number 26 is Moderna, which had a market cap of $17.10 billion on December 7 ...

Pharma and biotech bigwigs always look to bolster their product portfolios and pipelines through collaborations and buyouts. While oncology and immuno-oncology companies have always been ...

With dozens of companies in the clinical-stage ... This has translated into undervalued in several interesting biotech stocks under $10. An important point to note is that clinical-stage biotech ...

The cyclical, high-risk, high-reward nature of the biotech industry is on full display in 2024. This industry is centered on using living organisms and bioprocesses for innovative drug development ...

This List includes VC-funded biotech companies in Alameda, Contra Costa, Marin, Napa, San Francisco, San Mateo, Santa Clara, Solano and Sonoma counties. Information was obtained from PitchBook.

Yet, a troubling trend has emerged: over the past six years, 66 out of 67 biotech companies have chosen American IPOs, frequently opting for dual listings. This tendency towards ‘Americanisation ...